background image
Only Bovipast® RSP contains
Technology
Mannheim
ia (Past
eurella
)
RS
V
PI3
haemoly
tica
Bovilis Bovipast
®
RSP contains inact. BRS Virus strain EV908, Pi-3 Virus strain SF-4 Reisinger and Mannheimia haemolytica A1 strain M4/1. Bovilis
®
IBR Marker
Live contains live, attenuated IBR marker vaccine BHV-1 strain GK/D (gE_ ). For the active immunisation against infectious bovine rhinotracheitis virus.
Use medicines responsibly
Withdrawal periods: zero days. Legal Categories: ROI POM(E) NI POM-V .
For further information see SPC, contact prescriber or MSD Animal Health, Red Oak North, South County Business Park, Leopardstown, Dublin 18, Ireland.
Tel: +353(0)1 2970220. E-Mail: vet-support.ie@merck.com Web: www.msd-animal-health.ie
*Mannheimia (Pasteurella) haemolytica A1 and A6.
** Bovilis IBR Marker Live and Bovilis Bovipast RSP are licensed for use at the same time
from 3 weeks of age.
IE/BBR/0117/0002B SEPTEMBER 2018
TECHNOLOGY
TECHNOLOGY
Bovilis
®
IBR
Marker Live
and
Bovipast
®
RSP
**
Bovipast
®
RSP Vaccine Protocol
Provides protection against RSV, PI3 and the broadest
protection against Pasteurella*
Weanlings
5ml dose
Subcutaneous injection
into the side of the neck
2 weeks before
Weaning
6 weeks before
2 weeks before
Weaning
6 weeks before
What makes Bovipast
®
RSP different?
·
Bovipast
®
RSP
protects against 2 serotypes
of Mannheimia haemolytica - A1 and A6
·
IRP technology reduces Mannheimia
haemolytica* multiplying
·
Competitor vaccines do not contain IRP
technology and so may not provide the
same level of protection against Mannheimia
haemolytica*
as
Bovipast
®
RSP
Bovipast(Beef)-IRP IFM FP 10-18.indd 1
01/10/2018 10:14